Medopad, a British healthcare technology company based in London, has changed its name to Huma and acquired two UK-based AI and wearable technology businesses, BioBeats and Tarilian Laser Technologies (TLT). The rebrand and acquisitions support the company’s mission to use insights gathered by remote monitoring to help healthcare, life sciences and innovation partners understand, treat and prevent poor health.
Read more VitalConnect Adds Arrhythmia Detection to its Remote Patient Monitoring Platform
By collectively benefiting from the data people individually generate, Huma aims to give knowledge and power to individuals, while saving clinicians time, energy and valuable resources, says a press release.
“We’ve been through quite a journey since Medopad started in 2011. Medopad has specialized in remote patient monitoring for patients with rare and chronic diseases,” said Dan Vahdat, founder and CEO of Huma. “Over time, we’ve realized that health is about more than disease states; it’s about general physical and mental wellbeing go hand-in-hand. That’s why it makes perfect sense for us to evolve what the company stands for, what we offer, and why we do what we do. That’s why from today, Medopad is now Huma. Huma reflects our commitment to working with people, for people. The name Huma says that we’re for all of humanity.”
Mr Vahdat explained further, “Digital biomarkers may help tell us what causes disease, how they progress, and potentially how we can prevent disease. BioBeats and TLT enable our partners to have a more holistic sense of people’s health and wellbeing through better data.”
BioBeats is a London-based company dedicated to building validated digital mental health interventions and leading a new approach to wellbeing support through its flagship product, BioBase. The mobile app, paired with biosensors and a wearable device, gathers biometric data (e.g. heart rate variability) and psychometric measures (e.g. mood journaling) to provide users with a personalized wellbeing score, fostering an increased understanding of their mental wellbeing. Combining applied research and AI, BioBase improves mental health through tailored insights, biofeedback tools and digital therapeutics for a preventative mental health intervention, said a press release.
David Plans, BioBeats co-founder and CEO commented, “We share a vision with Huma for pioneering preventative health. We want people to go from simply surviving to thriving. By creating clinically-validated products to predict, diagnose and treat mental health disorders, we allow everyone to flourish. We are excited to join Huma to realize our ambition for preventative mental health and wellbeing to people around the world. With Huma’s experience, global partners and innovation capabilities, we look forward to joining the Huma team to help people live longer, fuller lives.”
Read more Current Health’s AI-Powered Remote Patient Monitoring Device Gets FDA Clearance
TLT is a Hertfordshire-based medical technology company that is pioneering an innovative breakthrough in blood pressure monitoring with an unobtrusive wearable device on a person’s wrist. This novel sensor utilizes light modulation to detect motion, including continuous beat-by-beat flow motion forces that determine arterial blood pressure.
